688289 圣湘生物
2024/03 - 三个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(125,646)43,5402,558,9471,877,0712,642,276
投资活动产生之现金流量净额(208,215)1,397,790(1,166,746)(1,112,221)(1,715,957)
筹资活动产生之现金流量净额421,060(369,110)(915,948)(688,591)1,609,901
汇率变动对现金及现金等价物的影响(1,827)345(10,008)(34,253)(44,586)
现金及现金等价物净增加/(减少)85,3711,072,564466,24442,0062,491,634
期初现金及现金等价物余额4,171,6143,099,0502,632,8062,590,80099,166
期末现金及现金等价物余额4,256,9854,171,6143,099,0502,632,8062,590,800